APPLICATION
ANDA214011
TYPE
ANDA
ORIGINAL APPROVAL
2021-10-15
LATEST ACTION
2026-01-30
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
ARSENIC TRIOXIDEDiscontinued
ARSENIC TRIOXIDE 2MG/ML · INJECTABLE · INJECTION
Approval history
2026-01-30Labeling · Supplement 4 · standardAP
2021-10-15UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.